Embry Holdings 미래 성장

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Embry Holdings 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

SEHK:1388 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (HKD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
6/30/2024	1,204	-160	-56	-44	N/A
3/31/2024	1,243	-116	-23	-3	N/A
12/31/2023	1,282	-72	10	38	N/A
9/30/2023	1,292	-60	53	85	N/A
6/30/2023	1,301	-47	95	133	N/A
3/31/2023	1,318	-49	109	139	N/A
12/31/2022	1,334	-51	124	145	N/A
9/30/2022	1,419	-55	139	155	N/A
6/30/2022	1,504	-59	154	166	N/A
3/31/2022	1,578	-43	157	168	N/A
12/31/2021	1,652	-27	160	171	N/A
9/30/2021	1,705	21	226	241	N/A
6/30/2021	1,757	69	291	310	N/A
3/31/2021	1,704	33	347	374	N/A
12/31/2020	1,650	-3	402	438	N/A
9/30/2020	1,751	-14	332	384	N/A
6/30/2020	1,852	-26	262	331	N/A
3/31/2020	2,060	27	168	260	N/A
12/31/2019	2,267	80	75	189	N/A
9/30/2019	2,282	91	-51	107	N/A
6/30/2019	2,297	102	-177	25	N/A
3/31/2019	2,374	127	-131	84	N/A
12/31/2018	2,452	151	-86	143	N/A
9/30/2018	2,481	337	41	214	N/A
6/30/2018	2,511	523	168	286	N/A
3/31/2018	2,425	509	N/A	227	N/A
12/31/2017	2,340	495	N/A	169	N/A
9/30/2017	2,282	296	N/A	188	N/A
6/30/2017	2,224	97	N/A	207	N/A
3/31/2017	2,220	98	N/A	204	N/A
12/31/2016	2,216	98	N/A	202	N/A
9/30/2016	2,268	122	N/A	197	N/A
6/30/2016	2,319	146	N/A	192	N/A
3/31/2016	2,427	174	N/A	190	N/A
12/31/2015	2,536	202	N/A	187	N/A
9/30/2015	2,536	205	N/A	164	N/A
6/30/2015	2,536	209	N/A	141	N/A
3/31/2015	2,460	198	N/A	138	N/A
12/31/2014	2,383	188	N/A	134	N/A
9/30/2014	2,360	194	N/A	158	N/A
6/30/2014	2,338	199	N/A	182	N/A
3/31/2014	2,286	199	N/A	222	N/A
12/31/2013	2,235	198	N/A	263	N/A

애널리스트 미래 성장 예측

수입 대 저축률: 1388 의 예상 수익 증가율이 절약률( 2.3% )보다 높은지 판단하기에는 데이터가 부족합니다.

수익 vs 시장: 1388 의 수익이 Hong Kong 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: 1388 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

수익 대 시장: 1388 의 수익이 Hong Kong 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: 1388 의 수익이 연간 20% 보다 빠르게 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 1388 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

Embry Holdings 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2022

Embry Holdings Limited Provides Sales Guidance for the Full Year Ending 31 December 2022

Embry Holdings Limited Provides Profit Guidance for Six Months Ended 30 June 2021

Embry Holdings Limited Provides Earnings Guidance for the Year Ended December of 2021

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021

Recent updates

Benign Growth For Embry Holdings Limited (HKG:1388) Underpins Its Share Price

First half 2024 earnings released: HK$0.20 loss per share (vs HK$0.013 profit in 1H 2023)

Embry Holdings Limited to Report First Half, 2024 Results on Aug 28, 2024

Full year 2023 earnings released: HK$0.17 loss per share (vs HK$0.12 loss in FY 2022)

Embry Holdings Limited, Annual General Meeting, May 23, 2024

Full year 2023 earnings released: HK$0.17 loss per share (vs HK$0.12 loss in FY 2022)

Embry Holdings Limited to Report Fiscal Year 2023 Results on Mar 21, 2024

Improved Revenues Required Before Embry Holdings Limited (HKG:1388) Shares Find Their Feet

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023

First half 2023 earnings released: EPS: HK$0.013 (vs HK$0.003 in 1H 2022)

Embry Holdings Limited to Report First Half, 2023 Results on Aug 24, 2023

Embry Holdings Appoints Mr. Chan Chi on as Director

Full year 2022 earnings released: HK$0.12 loss per share (vs HK$0.065 loss in FY 2021)

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2022

Less than half of directors are independent

Embry Holdings Limited Provides Sales Guidance for the Full Year Ending 31 December 2022

Does Embry Holdings (HKG:1388) Have A Healthy Balance Sheet?

First half 2022 earnings released: EPS: HK$0.003 (vs HK$0.078 in 1H 2021)

Embry Holdings Limited Provides Profit Guidance for Six Months Ended 30 June 2021

Less than half of directors are independent

Embry Holdings Limited Provides Earnings Guidance for the Year Ended December of 2021

Embry Holdings Limited Announces Resignation of Mr. Cheng Man Tai as Executive Director and Chairman, Effective 1 February 2022

Upcoming dividend of HK$0.02 per share

First half 2021 earnings released: EPS HK$0.078 (vs HK$0.092 loss in 1H 2020)

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021

Capital Allocation Trends At Embry Holdings (HKG:1388) Aren't Ideal

Embry Holdings Limited Approves Final Dividend for the Year Ended 31 December 2020

Upcoming dividend of HK$0.025 per share

Embry Holdings Limited Provides Group Financial Guidance for the First Quarter Ended 31 March 2021

Full year 2020 earnings released: HK$0.007 loss per share (vs HK$0.19 profit in FY 2019)

Looking For Steady Income For Your Dividend Portfolio? Is Embry Holdings Limited (HKG:1388) A Good Fit?

Embry Holdings Limited Proposes Final Dividend, Payable on 10 June 2021

Full year 2020 earnings released: HK$0.007 loss per share (vs HK$0.19 profit in FY 2019)

Embry Holdings Limited to Report Fiscal Year 2020 Final Results on Mar 18, 2021

New 90-day high: HK$1.11

Our Take On The Returns On Capital At Embry Holdings (HKG:1388)

New 90-day high: HK$1.05

Would Shareholders Who Purchased Embry Holdings' (HKG:1388) Stock Five Years Be Happy With The Share price Today?

Our Take On The Returns On Capital At Embry Holdings (HKG:1388)

New 90-day low: HK$0.99

New 90-day low: HK$1.00

First half earnings released

Earnings released

Embry Holdings Limited to Report First Half, 2020 Results on Aug 20, 2020

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견